INS and nonpapillary renal cell carcinoma: The insulin receptor (INSR) regulates the insulin signaling pathway and activates the oncogenic PI3K/Akt/mTOR pathway, and its high expression is inversely associated with patient survival in ccRCC and gastric cancer [58].